
Central Reach
Health information research and data development organization.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | $1.7b Valuation: $1.7b | Acquisition | |
Total Funding | 000k |
USD | 2018 | 2019 | 2020 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 47 % | 13 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Founded in 2012, CentralReach has established a significant position in the healthcare technology sector, specifically focusing on software for Applied Behavior Analysis (ABA), autism, and intellectual and developmental disabilities (IDD) care. The company was started by Andre Refay and Michael Penman, with Charlotte Fudge also playing a foundational role as the initial CEO. In 2018, Chris Sullens, a seasoned executive with a background in scaling SaaS companies like WorkWave, was appointed CEO to guide CentralReach through its next growth phase. This transition was supported by a significant investment from Insight Partners in February 2018, which has been the primary institutional investor, fueling the company's expansion.
CentralReach operates on a software-as-a-service (SaaS) model, generating revenue through subscriptions to its comprehensive platform. The company serves a diverse client base, ranging from small, startup ABA practices to large, enterprise-level multidisciplinary therapy providers, special education programs, and organizations focused on neurodiversity in the workplace. The platform is an end-to-end solution designed to streamline operations and enhance care delivery for professionals serving individuals with autism and related IDDs. Key features include electronic health records (EHR), practice management, billing and revenue cycle management, scheduling automation, and clinical data collection. The software is HIPAA-compliant and accessible via the web and a mobile application, enabling therapists to manage their work in various settings, including clinics, schools, and homes.
A core component of CentralReach's offering is its clinical suite, which provides tools for ABA practitioners to create, manage, and track therapy programs. This includes digital materials to replace traditional flashcards and tools for precision teaching. The platform is engineered to reduce administrative burdens, automate complex tasks, and allow clinicians to focus more on client care and outcomes. To further bolster its capabilities, CentralReach has pursued an aggressive acquisition strategy, integrating companies like Chartlytics, Thread Learning, and, more recently, AI-focused firms such as SpectrumAi and AI.Measures. These acquisitions have expanded its platform to include predictive analytics, video data capture, and outcomes-based care models, reinforcing its position in the market.
Keywords: Applied Behavior Analysis, ABA software, autism therapy, IDD care, practice management software, electronic health records, EHR, EMR, behavioral health technology, special education software, neurodiversity employment, clinical data collection, therapy billing, revenue cycle management, healthcare SaaS, Insight Partners, Roper Technologies, Chris Sullens, care delivery platform, outcomes-based care, clinical assessment tools
Tech stack
Investments by Central Reach
Edit



